Back to state act
Description
On 17 June 2022, the Norwegian Medicines Agency introduced an export ban on alteplase. More specifically, the export ban concerns powders and infusion/injection solutions. The export ban was introduce...
Sign in to see full description
Intervention Details
Intervention Type
Export ban
MAST Chapter
P: Export-related measures (incl. subsidies)
Implementation date
17 Jun 2022
Revocation date
01 Jul 2023
Implementation level
National
Affected flow
Outward
Announced as temporary
Yes
Eligible firms
all
Affected Trading Partners
Table
Affected Sectors
Sign in to access 1 sectors
Affected Products
Sign in to access 2 products
Threads
See all
This intervention is not part of any Thread yet.